Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Sangiovanni

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|August 8, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, et al.
United European Gastroenterology Journal|September 20, 2018
Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatmentGiulio Antonelli, Elia Gigante, Massimo Iavarone, et al.
Journal of Hepatology|September 30, 2021
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVRRoberta D'Ambrosio, Elisabetta Degasperi, Maria Paola Anolli, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
Cancers|April 14, 2026
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric ApproachEleonora Alimenti, Massimo Iavarone, Elia Fracas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regressionRoberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) GuidancePierpaolo Biondetti, Anna Maria Ierardi, Elena Casiraghi, et al.
Hepatology Communications|July 14, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinomaMassimo Iavarone, Eleonora Alimenti, Lorenzo Canova, et al.
Annals of Hepatology|May 1, 2019
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillanceMassimo Iavarone, Mauro Viganò, Nicole Piazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2019
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapyAlessandro Loglio, Massimo Iavarone, Mauro Viganò, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|August 8, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, et al.
United European Gastroenterology Journal|September 20, 2018
Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatmentGiulio Antonelli, Elia Gigante, Massimo Iavarone, et al.
Journal of Hepatology|September 30, 2021
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVRRoberta D'Ambrosio, Elisabetta Degasperi, Maria Paola Anolli, et al.
Digestive Diseases (Basel, Switzerland)|October 22, 2015
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance ImagingFabio Piscaglia, Massimo Iavarone, Marzia Galassi, et al.
Cancers|April 14, 2026
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric ApproachEleonora Alimenti, Massimo Iavarone, Elia Fracas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regressionRoberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.
Journal of Clinical Medicine|December 23, 2023
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) GuidancePierpaolo Biondetti, Anna Maria Ierardi, Elena Casiraghi, et al.
Hepatology Communications|July 14, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinomaMassimo Iavarone, Eleonora Alimenti, Lorenzo Canova, et al.
Annals of Hepatology|May 1, 2019
Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillanceMassimo Iavarone, Mauro Viganò, Nicole Piazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2019
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapyAlessandro Loglio, Massimo Iavarone, Mauro Viganò, et al.
Pageof 12